HCA Healthcare, Inc. announced its financial results for the second quarter of 2025, reporting revenues of $18.605 billion, a 6.4% increase from the same period in 2024. Net income rose to $1.653 billion, or $6.83 per diluted share, marking a 13.1% increase year-over-year. The company also reported an 8.4% increase in Adjusted EBITDA to $3.849 billion and significant growth in cash flows from operating activities, which totaled $4.210 billion compared to $1.971 billion in Q2 2024. Same facility admissions and equivalent admissions showed modest increases of 1.8% and 1.7%, respectively, while emergency room visits also increased slightly by 1.3%.
Additionally, HCA's Board of Directors declared a quarterly cash dividend of $0.72 per share, set to be paid on September 30, 2025, to stockholders of record by September 16, 2025. The company has $5.753 billion remaining under its share repurchase authorization and estimates capital expenditures of approximately $5.0 billion for the year. As of June 30, 2025, HCA had total assets of $59.536 billion and total debt of $44.483 billion, indicating a solid financial position amidst ongoing operations.
linkJul 25, 2025 07:46:01
HCA Healthcare has appointed John W. Chidsey, III as an independent director, effective July 15, 2025, increasing the board's size from nine to ten members. Mr. Chidsey will serve on several committees, including the Audit and Compliance Committee and the Compensation Committee. He brings significant experience from his previous roles as CEO of Subway and Burger King Holdings, along with leadership positions at Cendant Corporation and PepsiCo.
Mr. Chidsey's appointment is expected to provide valuable insights to HCA Healthcare, which operates 192 hospitals and approximately 2,500 ambulatory care sites in 20 states and the UK. The company is recognized for its commitment to patient care and has a history of conducting clinical studies aimed at improving health outcomes. His addition to the board aligns with HCA's focus on leveraging extensive leadership experience to enhance corporate strategy.
linkJul 11, 2025 16:21:03
HCA Inc. has established a commercial paper program allowing it to issue unsecured commercial paper notes up to a total of $4.0 billion. These notes will be unconditionally guaranteed by its parent company, HCA Healthcare, Inc., and can be borrowed, repaid, and reborrowed as needed. The proceeds from these notes will be utilized for general corporate purposes, with maturities not exceeding 397 days from the issuance date.
The notes will be sold in the U.S. commercial paper market on a private placement basis and will not be registered under the Securities Act of 1933 or state securities laws, meaning they cannot be offered or sold in the United States without proper registration or an exemption. This announcement does not constitute an offer to sell or solicit offers to buy any of the notes.
linkJun 10, 2025 16:10:30
HCA Healthcare, Inc. announced its financial results for the first quarter of 2025, reporting revenues of $18.321 billion and a net income of $1.610 billion, or $6.45 per diluted share. This marks an increase from $17.339 billion in revenues and $1.591 billion in net income, or $5.93 per diluted share, in the same quarter of 2024. The company also reported an adjusted EBITDA of $3.733 billion and a 2.6% increase in same facility admissions compared to the previous year. Cash flows from operating activities totaled $1.651 billion in the first quarter of 2025, down from $2.469 billion in the first quarter of 2024. Additionally, HCA Healthcare repurchased 7.762 million shares at a cost of $2.506 billion during this quarter, with $8.259 billion remaining under its repurchase authorization as of March 31, 2025.
The Board of Directors declared a quarterly cash dividend of $0.72 per share, scheduled to be paid on June 30, 2025, to stockholders of record as of June 16, 2025. As of March 31, 2025, HCA Healthcare's balance sheet included cash and cash equivalents of $1.060 billion and total debt of $44.576 billion. The company reaffirmed its 2025 estimated guidance ranges, reflecting expectations for volume growth and a stable operating environment. HCA Healthcare operates 192 hospitals and approximately 2,500 ambulatory sites across 20 states and the United Kingdom.
linkApr 25, 2025 07:48:16
The company has entered into an underwriting agreement with multiple financial institutions for the issuance and sale of Notes. This agreement involves several prominent underwriters, indicating a structured approach to raising capital in the market. The details of the agreement are included as an exhibit in the report, providing further transparency regarding the terms involved.
There are no specific financial metrics or performance indicators mentioned in the press release that highlight the company's current financial standing or future projections. The lack of detailed financial information could leave stakeholders without a clear understanding of how this agreement will impact the company's financial health.
linkFeb 21, 2025 16:10:38
The company has entered into a material definitive agreement, which signifies a new direct financial obligation. This agreement may impact the company's financial position and obligations moving forward.
Certain schedules and exhibits related to the agreement have been omitted, but the company has committed to providing these documents to the SEC upon request. The report concludes with the necessary signatures confirming the authenticity of the information presented.
linkFeb 20, 2025 17:15:04
HCA Healthcare, Inc. announced a proposed public offering of senior notes through its subsidiary, HCA Inc. The proceeds from this offering are intended for general corporate purposes, including potential repayment of existing borrowings. The offering will be managed by several financial institutions and is made under an effective shelf registration statement with the SEC, indicating a structured approach to securing funds.
However, the actual terms of the senior notes, such as maturity and interest rates, remain uncertain and will depend on market conditions at the time of pricing. This uncertainty may reflect broader market volatility and could impact the company's financial strategy. Additionally, the press release includes a disclaimer regarding forward-looking statements, emphasizing the inherent risks and uncertainties associated with such financial endeavors.
linkFeb 18, 2025 08:44:06
HCA Healthcare reported revenues of $18.285 billion for the fourth quarter of 2024, an increase from $17.303 billion in the same period last year. The company achieved a net income of $1.438 billion, or $5.63 per diluted share, despite facing an estimated impact of $0.60 per diluted share due to Hurricanes Helene and Milton. Adjusted EBITDA for the quarter rose to $3.712 billion, reflecting a solid performance in same facility admissions, which increased by 3.0 percent, and same facility equivalent admissions, which grew by 3.1 percent compared to the prior year. Additionally, HCA's cash flows from operating activities totaled $2.559 billion for the quarter.
On the downside, net income attributable to HCA decreased from $1.607 billion, or $5.93 per diluted share, in the fourth quarter of 2023 to $1.438 billion in Q4 2024. The company also incurred losses on sales of facilities amounting to $195 million, or $0.59 per diluted share. Furthermore, cash flows from operating activities decreased from $2.674 billion in Q4 2023. The financial impact of the hurricanes, which led to additional expenses and revenue losses estimated at $200 million for the quarter, also contributed to the decline in net income.
linkJan 24, 2025 07:40:45
HCA Healthcare announced impressive financial results for the third quarter of 2024, with revenues reaching $17.487 billion, a significant increase from $16.213 billion in the same quarter last year. The net income attributable to the company rose to $1.270 billion, or $4.88 per share, compared to $1.079 billion, or $3.91 per share, in 2023. The company also highlighted a 4.5% increase in same facility admissions and a strong cash flow from operations of $3.515 billion, reflecting robust operational performance despite challenges from two major hurricanes. The leadership praised the dedication and bravery of the staff during these events, emphasizing their commitment to patient care and community support.
However, HCA Healthcare faced some setbacks due to Hurricane Helene, which resulted in estimated losses of $50 million in the third quarter, and ongoing financial impacts expected in the fourth quarter could reach between $200 to $300 million. Additionally, the company anticipates that these disruptions may push its financial results toward the lower end of the guidance range for the year. Despite these challenges, HCA has declared a quarterly cash dividend of $0.66 per share, demonstrating confidence in its financial health and commitment to returning value to shareholders.
linkOct 25, 2024 07:38:49
The press release indicates that the company has complied with regulatory requirements by submitting its financial statements as mandated. This shows a commitment to transparency and adherence to legal obligations, which can positively influence investor confidence.
However, the release lacks specific details about the company's performance or strategic initiatives, which may leave stakeholders wanting more information. Without additional context or updates on business operations, the overall impact of the release remains limited.
linkAug 12, 2024 16:35:55